Journal of Urology

Oncology & Cancer

OnabotulinumtoxinA effect lasts in overactive bladder

(HealthDay)—OnabotulinumtoxinA treatment is safe and effective for long-term treatment of overactive bladder syndrome, according to a study published in the September issue of The Journal of Urology.

Surgery

Pre-op urine culture doesn't predict stone culture

(HealthDay)—For patients undergoing percutaneous stone removal, preoperative urine culture does not predict intraoperative stone culture results, according to a study published in the September issue of The Journal of Urology.

Oncology & Cancer

X-rays have low diagnostic yield for pulmonary metastases

(HealthDay)—For patients treated for T1a renal cell carcinoma, chest X-rays have low diagnostic yield for detecting pulmonary metastases, according to a study published in the August issue of The Journal of Urology.

Oncology & Cancer

MRI feasible for predicting prostate CA in unselected sample

(HealthDay)—Prostate multiparametric magnetic resonance imaging (MRI) is feasible for predicting prostate cancer in an unselected sample of the general population, according to a study published in the August issue of The ...

page 12 from 32